Mostrar registro simples

dc.contributor.authorRadfar, Seyed Raminpt_BR
dc.contributor.authorJong, Cornelis A. J. Dept_BR
dc.contributor.authorFarhoudian, Alipt_BR
dc.contributor.authorEbrahimi, Mohsenpt_BR
dc.contributor.authorRafei, Parnianpt_BR
dc.contributor.authorVahidi, Mehrnooshpt_BR
dc.contributor.authorYunesian, Masudpt_BR
dc.contributor.authorKouimtsidis, Christospt_BR
dc.contributor.authorArunogiri, Shalinipt_BR
dc.contributor.authorMassah, Omidpt_BR
dc.contributor.authorDeylamizadeh, Abbaspt_BR
dc.contributor.authorBrady, Kathleen T.pt_BR
dc.contributor.authorBusse, Anjapt_BR
dc.contributor.authorPotenza, Marc N.pt_BR
dc.contributor.authorEkhtiari, Hamedpt_BR
dc.contributor.authorBaldacchino, Alexander Mariopt_BR
dc.contributor.authorKessler, Felix Henrique Paimpt_BR
dc.contributor.authorISAM-PPIG Global Survey Consortiumpt_BR
dc.date.accessioned2023-08-01T03:34:09Zpt_BR
dc.date.issued2021pt_BR
dc.identifier.issn1664-0640pt_BR
dc.identifier.urihttp://hdl.handle.net/10183/262957pt_BR
dc.description.abstractBackground: The coronavirus disease 2019 (COVID-19) pandemic has impacted people with substance use disorders (SUDs) worldwide, and healthcare systems have reorganized their services in response to the pandemic. Methods: One week after the announcement of the COVID-19 as a pandemic, in a global survey, 177 addiction medicine professionals described COVID-19-related health responses in their own 77 countries in terms of SUD treatment and harm reduction services. The health responses were categorized around (1) managerial measures and systems, (2) logistics, (3) service providers, and (4) vulnerable groups. Results: Respondents from over 88% of countries reported that core medical and psychiatric care for SUDs had continued; however, only 56% of countries reported having had any business continuity plan, and 37.5% of countries reported shortages of methadone or buprenorphine supplies. Participants of 41% of countries reported partial discontinuation of harm-reduction services such as needle and syringe programs and condom distribution. Fifty-seven percent of overdose prevention interventions and 81% of outreach services were also negatively impacted. Conclusions: Participants reported that SUD treatment and harm-reduction services had been significantly impacted globally early during the COVID-19 pandemic. Based on our findings, we highlight several issues and complications resulting from the pandemic concerning people with SUDs that should be tackled more efficiently during the future waves or similar pandemics. The issues and potential strategies comprise the following: (1) helping policymakers to generate business continuity plans, (2) maintaining the use of evidence-based interventions for people with SUDs, (3) being prepared for adequate medication supplies, (4) integrating harm reduction programs with other treatment modalities, and (5) having specific considerations for vulnerable groups such as immigrants and refugees.en
dc.format.mimetypeapplication/pdfpt_BR
dc.language.isoengpt_BR
dc.relation.ispartofFrontiers in psychiatry. Lausanne. Vol. 12 (Apr. 2021), 639393, [16] p.pt_BR
dc.rightsOpen Accessen
dc.subjectCOVID-19pt_BR
dc.subjectCOVID-19 pandemicen
dc.subjectTranstornos relacionados ao uso de substânciaspt_BR
dc.subjectSubstance use disorderen
dc.subjectSaúde públicapt_BR
dc.subjectPublic healthen
dc.subjectTratamento de substituição de opiáceospt_BR
dc.subjectDrug policyen
dc.subjectServiços de saúdept_BR
dc.subjectOpioid agonist treatmenten
dc.subjectAddiction servicesen
dc.subjectRedução do danopt_BR
dc.subjectHarm reductionen
dc.titleReorganization of substance use treatment and harm reduction services during the COVID-19 pandemic : a global surveypt_BR
dc.typeArtigo de periódicopt_BR
dc.identifier.nrb001171663pt_BR
dc.type.originEstrangeiropt_BR


Thumbnail
   

Este item está licenciado na Creative Commons License

Mostrar registro simples